These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

330 related items for PubMed ID: 15108463

  • 1. [Clinical and hemodynamic efficacy of selective beta-blocker bisoprolol and cytoprotector trimetazidine in the treatment of chronic cardiac failure in patients with ischemic heart disease].
    Fedorova TA, Il'ina IuV, Sotnikova TI, Rybakova MK, Loshchits NV.
    Ter Arkh; 2004; 76(3):62-8. PubMed ID: 15108463
    [Abstract] [Full Text] [Related]

  • 2. [Potentialities of cytoprotection in the treatment of chronic heart failure in patients with coronary heart disease].
    Fedorova TA, Il'ina IuV, Sotnikova TI, Rybakova MK.
    Klin Med (Mosk); 2004; 82(11):15-20. PubMed ID: 15656392
    [Abstract] [Full Text] [Related]

  • 3. [Efficacy of a cardioselective beta1-adrenoblocker bisoprolol in patients with chronic obstructive pulmonary disease in combination with ischemic heart disease].
    Tsvetkova OA, Veselovskaia MV.
    Ter Arkh; 2007; 79(3):25-9. PubMed ID: 17526191
    [Abstract] [Full Text] [Related]

  • 4. A randomized clinical trial of trimetazidine, a partial free fatty acid oxidation inhibitor, in patients with heart failure.
    Fragasso G, Palloshi A, Puccetti P, Silipigni C, Rossodivita A, Pala M, Calori G, Alfieri O, Margonato A.
    J Am Coll Cardiol; 2006 Sep 05; 48(5):992-8. PubMed ID: 16949492
    [Abstract] [Full Text] [Related]

  • 5. [Decrease in the sensitivity to the anti-ischemic effect of propranolol and prospects for correcting it in patients with stable angina pectoris].
    Butina EK, Kokurina EV, Dmitrieva NA, Bochkareva EV.
    Ter Arkh; 2002 Sep 05; 74(9):36-41. PubMed ID: 12418118
    [Abstract] [Full Text] [Related]

  • 6. [Optimization of use of beta-adrenoblockers in the treatment of chronic heart failure in the outpatient setting].
    Zhubrina ES, Ovchinnikov AG, Seredenina EM, Patrusheva IF, Blankova ZN, Kuz'mina AE, Kheĭmets GI, Ageev FT.
    Ter Arkh; 2009 Sep 05; 81(11):35-40. PubMed ID: 20141011
    [Abstract] [Full Text] [Related]

  • 7. Physical training in patients with chronic heart failure of ischemic origin: effect on exercise capacity and left ventricular remodeling.
    Klecha A, Kawecka-Jaszcz K, Bacior B, Kubinyi A, Pasowicz M, Klimeczek P, Banyś R.
    Eur J Cardiovasc Prev Rehabil; 2007 Feb 05; 14(1):85-91. PubMed ID: 17301632
    [Abstract] [Full Text] [Related]

  • 8. Effect on survival and hospitalization of initiating treatment for chronic heart failure with bisoprolol followed by enalapril, as compared with the opposite sequence: results of the randomized Cardiac Insufficiency Bisoprolol Study (CIBIS) III.
    Willenheimer R, van Veldhuisen DJ, Silke B, Erdmann E, Follath F, Krum H, Ponikowski P, Skene A, van de Ven L, Verkenne P, Lechat P, CIBIS III Investigators.
    Circulation; 2005 Oct 18; 112(16):2426-35. PubMed ID: 16143696
    [Abstract] [Full Text] [Related]

  • 9. Design of the cardiac insufficiency bisoprolol study II (CIBIS II). The CIBIS II Scientific Committee.
    Fundam Clin Pharmacol; 1997 Oct 18; 11(2):138-42. PubMed ID: 9107560
    [Abstract] [Full Text] [Related]

  • 10. Effect of bisoprolol on perioperative complications in chronic heart failure after surgery (Cardiac Insufficiency Bisoprolol Study II (CIBIS II)).
    Böhm M, Maack C, Wehrlen-Grandjean M, Erdmann E.
    Z Kardiol; 2003 Aug 18; 92(8):668-76. PubMed ID: 12955414
    [Abstract] [Full Text] [Related]

  • 11. Impact of statin therapy on clinical outcomes in chronic heart failure patients according to beta-blocker use: results of CIBIS II.
    Krum H, Bailey M, Meyer W, Verkenne P, Dargie H, Lechat P, Anker S.
    Cardiology; 2007 Aug 18; 108(1):28-34. PubMed ID: 16960445
    [Abstract] [Full Text] [Related]

  • 12. Effect of trimetazidine on quality of life in elderly patients with ischemic dilated cardiomyopathy.
    Marazzi G, Gebara O, Vitale C, Caminiti G, Wajngarten M, Volterrani M, Ramires JA, Rosano G, Fini M.
    Adv Ther; 2009 Apr 18; 26(4):455-61. PubMed ID: 19396409
    [Abstract] [Full Text] [Related]

  • 13. [Physical rehabilitation in the complex hospital therapy of patients with chronic low cardiac output].
    Efremushkin GG, Antropova ON, Osipova IV.
    Ter Arkh; 2003 Apr 18; 75(12):50-4. PubMed ID: 14959471
    [Abstract] [Full Text] [Related]

  • 14. [Assessment of the efficacy of bisoprolol administration by cardiopulmonary exercise testing in patients with heart failure].
    Terzi S, Dayi SU, Akbulut T, Dağ O, Köse H, Satiroğlu O, Sayar N, Bilsel T, Aksoy S, Yeşilçimen K.
    Anadolu Kardiyol Derg; 2003 Dec 18; 3(4):313-8. PubMed ID: 14675880
    [Abstract] [Full Text] [Related]

  • 15. Influence of order and type of drug (bisoprolol vs. enalapril) on outcome and adverse events in patients with chronic heart failure: a post hoc analysis of the CIBIS-III trial.
    Funck-Brentano C, van Veldhuisen DJ, van de Ven LL, Follath F, Goulder M, Willenheimer R, CIBIS-III investigators.
    Eur J Heart Fail; 2011 Jul 18; 13(7):765-72. PubMed ID: 21551161
    [Abstract] [Full Text] [Related]

  • 16. [Trimetazidine effects on postinfarction remodeling of the left ventricle].
    Kokov AN, Tarasov II, Barbarash LS.
    Ter Arkh; 2005 Jul 18; 77(8):10-4. PubMed ID: 16206598
    [Abstract] [Full Text] [Related]

  • 17. Trimetazidine and reduction in mortality and hospitalization in patients with ischemic dilated cardiomyopathy: a post hoc analysis of the Villa Pini d'Abruzzo Trimetazidine Trial.
    Di Napoli P, Di Giovanni P, Gaeta MA, Taccardi AA, Barsotti A.
    J Cardiovasc Pharmacol; 2007 Nov 18; 50(5):585-9. PubMed ID: 18030070
    [Abstract] [Full Text] [Related]

  • 18. [Clinical efficacy of combined therapy with enalapril + trimetazidine in patients with hypertension comorbid with ischemic heart disease and metabolic disturbances].
    Petelina TI, Gapon LI, Bakhmatova IuA, Zhevagina IA.
    Ter Arkh; 2005 Nov 18; 77(8):19-23. PubMed ID: 16206600
    [Abstract] [Full Text] [Related]

  • 19. [MRT assessment of metabolic and thrombolytic therapy effects on postinfarction left ventricular remodeling].
    Tarasov NI, Kokov AN, Barbarash LS.
    Ter Arkh; 2006 Nov 18; 78(9):38-43. PubMed ID: 17076223
    [Abstract] [Full Text] [Related]

  • 20. [Viable myocardium: comparative evaluation of surgical and pharmacological treatment of patients with ischemic heart disease, post-infarct cardiosclerosis and chronic cardiac failure].
    Saidova MA, Belenkov IuN, Akchurin RS, Sergienko VB, Khodareva EN, Kostrova VV.
    Ter Arkh; 2002 Nov 18; 74(2):60-4. PubMed ID: 11899830
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.